Canada Impacted As Trump Imposes 25% Tariffs On Steel And Aluminum
Canada is likely to be impacted as U.S. President Donald Trump moves to impose 25% tariffs on American imports of steel and aluminum.Canada is currently the largest exporter of both industrial products to the U.S. and will feel the impacts of the tariffs more than any other nation, say analysts and economists. Trump said the new 25% levies would be in addition to existing duties. Steel and aluminum are vital components in various industries, including transportation, construction, and packaging.That said, U.S. steel imports have declined substantially over the past decade, dropping 35% between 2014 and 2024. The decline is due largely to tariffs introduced under Trump’s first term. America’s aluminum imports, however, have risen 14% over the last decade, with much of the increase coming from Canada. During his first presidency, Trump slapped tariffs on steel and aluminum imports from Canada, Mexico and Europe. His administration also placed volume limits on imports from other nations. The Congressional Research Service found that in the first five months of the 2018 duties being levied, the Trump administration collected more than $1.4 billion U.S. in revenue.The new tariffs on steel and aluminum come even after Canada and Mexico were granted a temporary respite from blanket duties on all their exports to the U.S. until March 1. Canada currently exports more steel to the U.S. than the rest of the world combined, according to data from the U.S. International Trade Administration.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


